Create Health
41 – 50 of 1025
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Revival of recombinant IL-2 therapy–approaches from the past until today
(
- Contribution to journal › Scientific review
-
Mark
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
(
- Contribution to journal › Article
-
Mark
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
(
- Contribution to journal › Article
-
Mark
Identification of Quantitative Trait Nucleotides and Development of Diagnostic Markers for Nine Fatty Acids in the Peanut
(
- Contribution to journal › Article
- 2023
-
Mark
Systemic chemotherapy with or without hepatic arterial infusion chemotherapy for liver metastases from pancreatic cancer: a propensity score matching analysis
(
- Contribution to journal › Article
-
Mark
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis : a prospective study
(
- Contribution to journal › Article
-
Mark
A proteomics dataset capturing myeloid cell responses upon cellular exposure to fungicides, adjuvants and fungicide formulations
(
- Contribution to journal › Article
-
Mark
Subclass-switched anti-Spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
(
- Contribution to journal › Article
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
(
- Contribution to journal › Article
-
Mark
Protective non-neutralizing mAbs Ab94 and Ab81 retain high-affinity and potent Fc-mediated function against SARS-CoV-2 variants from Omicron to XBB1.5
2023)(
- Working paper/Preprint › Preprint in preprint archive